filings.toolsItem 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
4K characters. Original on sec.gov · Markdown
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock began trading on the New York Stock Exchange under the symbol “PFG” on October 23, 2001. Prior to such date, there was no established public trading market for our common stock. Effective December 15, 2017, we changed our listing to the Nasdaq Global Select Market and continue trading under the symbol “PFG”. On January 30, 2025, there were 201,942 stockholders of record of our common stock.
We have historically paid cash dividends on our common stock. Future dividend decisions will be based on and affected by a number of factors, including our results and financial requirements and the impact of regulatory restrictions. See Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources” for a discussion of regulatory restrictions on Principal Life’s ability to pay dividends or make other distributions.
The following table presents the amount of our share purchase activity for the periods indicated:
| | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | Total number | Maximum dollar | ||||||
| | | | | | | | of shares | | value of shares | ||
| | | | | | | | purchased as | | that may yet be | ||
| | | Total number | | Average | | part of publicly | | purchased under | |||
| | | of shares | | price paid | | announced | | the programs | |||
| Period | | purchased (1) | | per share | | programs | | (in millions) (2) | |||
| January 1, 2024 - January 31, 2024 | 706,696 | | $ | 79.07 | 706,696 | | $ | 232.0 | | ||
| February 1, 2024 - February 29, 2024 | 860,430 | | $ | 79.04 | 740,658 | | $ | 1,673.5 | | ||
| March 1, 2024 - March 31, 2024 | 1,354,115 | | $ | 81.47 | | 1,051,468 | | $ | 1,587.7 | | |
| April 1, 2024 - April 30, 2024 | 1,214,041 | | $ | 81.80 | | 1,213,500 | | $ | 1,488.5 | | |
| May 1, 2024 - May 31, 2024 | 1,406,551 | | $ | 82.46 | | 1,406,551 | | $ | 1,372.5 | | |
| June 1, 2024 - June 30, 2024 | 438,010 | | $ | 79.82 | | 435,299 | | $ | 1,337.7 | | |
| July 1, 2024 - July 31, 2024 | 1,167,924 | | $ | 82.63 | | 1,162,868 | | $ | 1,241.6 | | |
| August 1, 2024 - August 31, 2024 | 1,932,449 | | $ | 76.58 | | 1,931,932 | | $ | 1,093.7 | | |
| September 1, 2024 - September 30, 2024 | 80,351 | | $ | 91.51 | | 74,621 | | $ | 1,086.8 | | |
| October 1, 2024 - October 31, 2024 | 1,587,784 | | $ | 86.87 | | 1,587,553 | | $ | 948.9 | | |
| November 1, 2024 - November 30, 2024 | 1,158,412 | | $ | 84.37 | 1,157,569 | | $ | 851.2 | | ||
| December 1, 2024 - December 31, 2024 | 761,873 | | $ | 85.39 | 761,496 | | $ | 786.2 | | ||
| Total | 12,668,636 | | 12,230,211 | | |
| (1) | Includes the number of shares of common stock utilized to execute certain stock incentive awards and shares purchased as part of publicly announced programs. |
|---|
| (2) | In January 2022, our Board authorized a $1.6 billion increase to the June 2021 share repurchase program authorization, which was completed in April 2024. In February 2024, our Board authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which has no expiration date. In February 2025, our Board authorized a share repurchase program of up to $1.5 billion of our outstanding common stock, which has no expiration date, and is in addition to the $786.2 million that remained available under existing share repurchase authorizations as of December 31, 2024. |
|---|
Previous: Item 3. Legal Proceedings · Next: Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations